Literature DB >> 29427813

Life After the Neurosurgical Ward in Sub-Saharan Africa: Neurosurgical Treatment and Outpatient Outcomes in Uganda.

Linda W Xu1, Silvia D Vaca2, Juliet Nalwanga3, Christine Muhumuza4, Daniel Vail2, Benjamin J Lerman2, Joel Kiryabwire3, Hussein Ssenyonjo3, John Mukasa3, Michael Muhumuza3, Michael M Haglund5, Gerald Grant2.   

Abstract

BACKGROUND: In the past decade, neurosurgery in Uganda experienced increasing surgical volume and a new residency training program. Although research has examined surgical capacity, minimal data exist on the patient population treated by neurosurgery and their eventual outcomes in sub-Saharan Africa.
METHODS: Patients admitted to Mulago National Referral Hospital neurosurgical ward over 2 years (2014 and 2015) were documented in a prospective database. In total, 1167 were discharged with documented phone numbers and thus eligible for follow-up. Phone surveys were developed and conducted in the participant's language to assess mortality, neurologic outcomes, and follow-up health care.
RESULTS: During the study period, 2032 patients were admitted to the neurosurgical ward, 80% for traumatic brain injury. A total of 7.8% received surgical intervention. The in-hospital mortality rate was 18%. A total of 870 patients were reached for phone follow-up, a 75% response rate, and 30-day and 1-year mortality were 4% and 8%, respectively. Almost one-half of patients had not had subsequent health care after the initial encounter. Most patients had Glasgow Outcome Scale-Extended scores consistent with good recovery and mild disability, with patients experiencing trauma faring best and patients with tumor faring worst. A total of 85% felt they returned to baseline work performance, and 76% of guardians felt that children returned to baseline school performance.
CONCLUSIONS: The neurosurgical service provided health care to a large proportion of nonoperative patients. Phone surveys captured data on patients in whom nearly one-half would be lost to subsequent health care. Although mortality during initial hospitalization was high, more than 90% of those discharged survived at 1-year follow up, and the vast majority returned to work and school.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Follow-up; Global neurosurgery; Neurosurgical outcomes; Sub-Saharan Africa; Uganda

Mesh:

Year:  2018        PMID: 29427813     DOI: 10.1016/j.wneu.2018.01.204

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Pattern and frequency of neurological and neurosurgical care of adult inpatients and outpatients at a tertiary referral hospital in Kenya.

Authors:  Jane R von Gaudecker; Chrispine Oduor; Susan Ofner; Eren Oyungu; Jamil Said; Janice Buelow
Journal:  eNeurologicalSci       Date:  2020-11-02

2.  The need for a central brain tumor registry in Africa: A review of central nervous system tumors in Africa from 1960 to 2017.

Authors:  Marilyn Keng-Nasang Mbi Feh; Kristopher A Lyon; Ankita V Brahmaroutu; Ramya Tadipatri; Ekokobe Fonkem
Journal:  Neurooncol Pract       Date:  2021-01-27

Review 3.  A Systematic Review of Neurosurgical Care in Low-Income Countries.

Authors:  Hannah K Weiss; Roxanna M Garcia; Jesutofunmi A Omiye; Dominique Vervoort; Robert Riestenberg; Ketan Yerneni; Nikhil Murthy; Annie B Wescott; Peter Hutchinson; Gail Rosseau
Journal:  World Neurosurg X       Date:  2019-12-09

Review 4.  Telemedicine in Surgical Care in Low- and Middle-Income Countries: A Scoping Review.

Authors:  Eyitayo Omolara Owolabi; Tamlyn Mac Quene; Johnelize Louw; Justine I Davies; Kathryn M Chu
Journal:  World J Surg       Date:  2022-04-15       Impact factor: 3.282

Review 5.  Remote Follow-Up Technologies in Traumatic Brain Injury: A Scoping Review.

Authors:  Brandon G Smith; Stasa Tumpa; Orla Mantle; Charlotte J Whiffin; Harry Mee; Davi J Fontoura Solla; Wellingson S Paiva; Virginia F J Newcombe; Angelos G Kolias; Peter J Hutchinson
Journal:  J Neurotrauma       Date:  2022-10       Impact factor: 4.869

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.